RAP 0.00% 20.5¢ raptor resources limited

Ann: Clinical study to develop COVID-19 screening test, page-20

  1. 26,949 Posts.
    lightbulb Created with Sketch. 1741
    Too late for what? We invested in ResAppDx, this is the product that has massive revenue potential....DYOR.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.